New antidepressants for old people?: The evidence that newer drugs are much better than the old is thin

BMJ

Volumn 318, Issue 7199, 1999, Pages 1640-1641

  Livingston, Martin G ^a   Livingston, Hilary M ^a  

^a SOUTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; DOSULEPIN; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; MILNACIPRAN; MIRTAZAPINE; MOCLOBEMIDE; MONOAMINE OXIDASE A INHIBITOR; NEFAZODONE; PAROXETINE; PLACEBO; REBOXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

CLINICAL TRIAL; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; GERONTOPSYCHIATRY; PRIORITY JOURNAL;

AGED; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; HUMANS;

EID: 0033584007     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.318.7199.1640     Document Type: Editorial

References (16)

1. Hammerlein A, Derendorf H, Lowenthal DT. Pharmacokinetic and pharmacodynamic changes in the elderly. Clinical implications. Clin Pharmacokinet 1998; 35: 49–64.
2. Prescription Pricing Authority. Depression and antidepressants. Newcastle upon Tyne: PPA, 1995.
3. Edwards JG. Drug choice in depression. Selective serotonin reuptake inhibitors or tricyclic antidepressants? CNS Drugs 1995; 4: 141–159.
4. Song F, Freemantle N, Sheldon TA, House A, Watson P, Long A, et al. Selective serotonin inhibitors in depression: A meta analysis of efficacy and acceptability. BMJ 1993; 306: 683–687.
5. Evans M, Hammond M, Wilson K, Lye M, Copeland J. Placebo controlled treatment trial of depression in elderly physically ill patients. Int J Geriat Psych 1997; 12: 817–824.
6. Nyth AL, Gottfries CG, Lyby K, Smedegaard-Andersen L, Gylding-Sabroe J, Kristensen M, et al. A controlled multicenter trial of citalopram and placebo in elderly depressed patients with and without concomitant dementia. Acta Psych Scand 1992; 86: 138–145.
7. Roth M, Mountjoy CQ, Amrein R. Moclobemide in elderly patients with cognitive decline and depression; an international double blind placebo controlled trial. Br J Psych 1996; 168: 149–157.
8. Evans ME. Development and validation of a screening test for depression in the elderly physically ill. Int Clin Psychopharmacol 1993; 8: 329–331.
9. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed. Washington DC: APA, 1987.
10. Rahman MK, Akhtar MJ, Savla NC, Sharma RR, Kellett JM, Ashford JJ. A double blind randomised comparison of fluvoxamine with dothiepin in the treatment of depression in elderly patients. Br J Clin Pract 1991; 45: 255–258.
11. Tignol J, Pujol-Domenech J, Chartres JP, L'eger JM, Pl'etan Y, Tonelli I, et al. Double blind study of the efficacy and safety of milnacipran and imipramine in elderly patients with major depressive episode. Acta Psych Scand 1998; 97: 157–165.
12. Hutchinson DR, Tong S, Moon CA, Vince M, Clarke A. Paroxetine in the treatment of elderly depressed patients in general practice; a double blind comparison with amitriptyline. Int Clin Psychopharmacol 1992;suppl 4:43–51.
13. Cohn CK, Shrivastava R, Mendels J, Cohn JB, Fabre LF, Claghorn JL, et al. Double blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients. J Clin Psych 1990; 51 (suppl B): 28–33.
14. Mahapatra SN, Hackett D. A randomised double blind parallel group comparison of venlafaxine and dothiepin in geriatric patients with major depression. Int J Clin Pract 1997; 51: 209–213.
15. Reifler BV, Larson E, Henley R. Coexistence of cognitive impairment and depression in geriatric outpatients. Am J Psych 1982; 39: 623–626.
16. Henry JA. Epidemiology and relative toxicity of antidepressant drugs in overdose. Drug Safety 1997; 16: 374–390.